AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.75%)
As of: Sep 4, 2026 · 3:19 PM EDT

AtaiBeckley (ATAI) Long-Term Debt Issuances (2020 - 2025)

AtaiBeckley (ATAI) posted Long-Term Debt Issuances of -$5.0 million for Q4 2024, down 148.24% sequentially from $10.4 million in Q4 2022.

Analysis

AtaiBeckley (ATAI) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

AtaiBeckley has reported Long-Term Debt Issuances for 4 years, with the latest figure at -$5.0 million in Q4 2024.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$5.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.4 million (down 61.47% YoY) and the FY2022 annual result came in at $15.0 million, up 520.6% from the prior year.
  • Long-Term Debt Issuances retreated to -$5.0 million in Q4 2024 per ATAI's latest filing, from $10.4 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $18.1 million in Q3 2020 and troughed at -$5.0 million in Q4 2024.
  • A 4-year average of $4.9 million and a median of $3.0 million in 2021 frame the typical range for Long-Term Debt Issuances.
  • The sharpest annual moves came in 2021 and 2022: Long-Term Debt Issuances sank 105.95% in 2021, then soared 328.84% in 2022.
  • Over 4 years, Long-Term Debt Issuances stood at $5.8 million in 2020, then slumped by 58.33% to $2.4 million in 2021, then jumped by 328.84% to $10.4 million in 2022, then plunged by 148.24% to -$5.0 million in 2024.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods registered -$5.0 million, $10.4 million, and $3.6 million for Q4 2024, Q4 2022, and Q3 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 AtaiBeckley 1.61 Bn 1.61 Bn - 40.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 40.00 Mn
Jun 30, 2025 18.39 Mn
Jun 30, 2025 18.39 Mn
Mar 31, 2025 59.77 Mn
Mar 31, 2025 59.77 Mn
Sep 30, 2024 5.00 Mn
Dec 31, 2023 20,000.00
Sep 30, 2022 13.92 Mn
Jun 30, 2022 1.08 Mn
Dec 31, 2021 787,000.00
Sep 30, 2021 4.48 Mn
Jun 30, 2021 832,000.00
Mar 31, 2021 756,000.00
Dec 31, 2020 7.00 Mn
Sep 30, 2020 18.06 Mn
Jun 30, 2020 9.71 Mn